A K Halperin, L X Cubeddu. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antihypertensive Agents/therapeutic useBlood Pressure/drug effectsCalcium Channel Blockers/pharmacologyCalcium Channel Blockers/therapeutic useClinical Trials as TopicDiltiazem/administration & dosageDiltiazem/adverse effectsDiltiazem/metabolismDiltiazem/pharmacologyDouble-Blind MethodDrug InteractionsDrug Therapy, CombinationFollow-Up StudiesHeart Rate/drug effectsHemodynamics/drug effectsHumansHypertension/drug therapyKidney/drug effectsKineticsLabetalol/pharmacologyLabetalol/therapeutic useNifedipine/administration & dosageNifedipine/adverse effectsNifedipine/metabolismNifedipine/pharmacologySympathetic Nervous System/drug effectsVerapamil/administration & dosageVerapamil/adverse effectsVerapamil/metabolismVerapamil/pharmacology
Substances: See more » Antihypertensive AgentsCalcium Channel BlockersVerapamilDiltiazemNifedipineLabetalol
Year: 1986 PMID: 3511651 DOI: 10.1016/0002-8703(86)90154-7
Source DB: PubMed Journal: Am Heart J ISSN: 0002-8703 Impact factor: 4.749